Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings

xloma.fota13 shared this article with you from Inoreader Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings Via Drugs.com - FDA MedWatch Alerts Audience: Consumer, Patient, Health Professional, Pharmacy February 03, 2021 -- Apotex Corp is voluntarily recalling two (2) batches of Enoxaparin Sodium Injection, USP to consumer level due to a packaging error resulting in some syringes barrels... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.